A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood
Clinical trial NCT06367153 · COMPLETED
Trial details
- NCT number
- NCT06367153
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2024-08-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.